P1520: PROGNOSTIC IMPACT OF FEBRILE NEUTROPENIA AND DOSE INTENSITY OF R-CHOP THERAPY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, A SUPPLEMENTARY ANALYSIS OF JCOG0601

• Isao Yoshida,
• Ken Ohmachi,
• Naomi Konishi,
• Ryunosuke Machida,
• Dai Maruyama,
• Wataru Munakata,
• Tsutomu Kobayashi,
• Tomohiro Kinoshita,
• Kiyoshi Ando,
• Hirokazu Nagai

Affiliations

Isao Yoshida

1 National Hospital Organization Shikoku Cancer Center, Hematologic Oncology, Matsuyama, Japan

Ken Ohmachi

2 Tokai University Hospital, Hematology and Oncology, Isehara, Japan

Naomi Konishi

3 National Cancer Center Hospital, JCOG Data Center, Tokyo, Japan

Ryunosuke Machida

3 National Cancer Center Hospital, JCOG Data Center, Tokyo, Japan

Dai Maruyama

4 Cancer Institute Hospital, Japanese Foundation for Cancer Research, Hematology Oncology, Tokyo, Japan

Wataru Munakata

5 National Cancer Center Hospital, Hematology, Tokyo, Japan

Tsutomu Kobayashi

6 Japanese Red Cross Kyoto Daiichi Hospital, Hematology, Kyoto, Japan

Tomohiro Kinoshita

7 Aichi Cancer Center, Hematology and Cell Therapy, Nagoya, Japan

Kiyoshi Ando

2 Tokai University Hospital, Hematology and Oncology, Isehara, Japan

Hirokazu Nagai

8 National Hospital Organization Nagoya Medical Center, Hematology, Nagoya, Japan